More stories
Healing Psychedelics: Where Science Meets Spirit
Does combining the knowledge from Indigenous traditions with more research-backed Western frameworks land us in the sweet spot where science meets spirit? In this...
Pα+ Psychedelic Bulletin #175: atai Sells a Third of Compass Stake; Lykos’ Unproven Psychotherapy...
SEC filings reveal that last week atai Life Sciences disposed of around 2.7 million Compass Pathways shares for gross proceeds of just over $16...
The Hidden Roots of Australia’s Psychedelic Underground
Australia’s relationship with psychedelics has taken a dramatic turn in recent years – but beneath the surface, an enduring underground movement has quietly shaped...
The Globalization of Ayahuasca, Psychedelic Parenting, and the Power of Ceremony
Is the globalization of ayahuasca hurting tradition and taking ayahuasca further away from its Indigenous roots? Or is it spreading its culture to the...
The Psychedelics Lobby: Tracking Federal Lobbying by Psychedelics Companies and Nonprofits
With just over one month to go until Americans head to the polls, we’re taking a look at federal lobbying on psychedelics-related matters. Here,...
Tripped: The Connection Between LSD, Nazi Germany, and MKUltra
Researching the true history of substances deemed illegal can lead to surprising results. In the case of LSD, does its history include a connection...
Pα+ Psychedelic Bulletin #174: Psilocybin Outperforms Escitalopram After 6 Months… or Does It? Survey...
Last Saturday, 6-month follow-up data from Imperial College London’s psilocybin vs. escitalopram in major depressive disorder (MDD) study was published (Erritzoe et al., 2024)....
Ancestral Knowledge: Why Understanding the Ancient is Crucial for Western Psychedelic Explorers
In the communities of the Shipibo people in the Peruvian Amazon, there are healers known as onayas and witches known as yubés. During ayahuasca...
Intention, Making Space for Integration, and Finding Joy in the Mundane
With so much attention being placed on the psychedelic experience itself, too many people are getting stuck in patterns of chasing the experience without...
Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises Preparing for Resubmission...
As the news cycle becomes less consumed by Lykos (though, there is a short piece below), we’re looking ahead to upcoming sponsored psychedelic trial...
Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?
After years of work, MAPS/Lykos was finally able to present MDMA to the FDA as a possible tool in the fight against PTSD, only...
